Cardiovascular Disease Related Peptides Are Now Accessible at Creative Peptides

NEW YORK, NY - Aug 29, 2019 - Having been dedicated to the great cause of supplying peptides for nearly two decades, the New York-based brand Creative Peptides recently adds another major peptide category for scientists who are involved with cardiovascular disease research. Earlier this year, special product lines have already been designed for research on Alzheimer's, cancer, diabetes, and immunotherapy.

Cardiovascular disease (CVD) are generally referred to diseases that are related to heart or blood vessels. Accordingly to statistics, roughly 610,000 people (i.e. 1 in every 4) in the US die of heart disease each year, which makes it the leading cause of death for both men and women. Common cardiovascular diseases include coronary artery syndrome, stroke, hypertensive heart disease, aneurysm, cardiomyopathy, rheumatic heart disease, atrial fibrillation, congenital heart disease, endocarditis, and peripheral artery obstructive disease, whose pathogenesis differs from each other.

"Back to a long time, researchers have been actively studying the cause of cardiovascular disease, with high blood pressure, lack of exercise, obesity, smoking, diabetes, hyperlipidemia, poor eating habits and excessive drinking being the suspects,"says Dr. Robert Martinez, spokesperson from Creative Peptides. "Generally speaking, early detection and action is very important for the cure and survival of heart attack. Lifestyle changes, medications as well as medical procedures or surgery are viewed as the three major treatment approaches. But in recent years, proteins and peptides with unique biological activity and metabolism have successfully caught the attention of researchers as an alternative treatment for cardiovascular diseases. Owing to their strong ability to resist inflammatory cell reaction, these peptides have great potentials in the prevention and reduction of the occurrence of CVD.”

Some studies have shown that regulatory pathways of CVD are potentially modulated by dietary proteins and peptides. Meanwhile, further studies have also shown that RGD peptides regulate a variety of inflammatory pathways in macrophages.

The thought of developing peptides as therapeutic agents for CVD has been avoided historically by the pharmaceutical industry, as they doubt peptides’ disadvantages like low stability, size, rate of degradation, and poor delivery. It is only until more recently that resurgence has taken place in developing peptides and their mimetics for therapeutic intervention.

"This is a positive sign to see that more peptides are used to mimic the function of mediators involved in pathologic processes during vascular damage," continues to explain Dr. Martinez. “We have faith that in the near future, a more effective peptide-based treatment for CVD diseases will be found with such researches being carried out in a larger scale.”

The CVD related peptides at Creative Peptides are wide-ranged. For more detailed information, please visit: https://www.creative-peptides.com/research-areas/cvd-related-peptides.html.

About Creative Peptides

With over a dozen of years’ experience in peptide manufacturing and synthesis, Creative Peptides has now gained a fame in amino acids modification, custom peptide synthesis, epitope mapping, stapled peptide synthesis, GMP manufacturing, peptide drug discovery as well as supplying pancreastatin, API peptides, cosmetic peptides, fibronectin fragments, matrix metalloproteinase substrates, catalog peptides, cell penetrating peptides, etc.